News
News

The latest updates from AFAR.

Board Member in the News: Scientific Director Steven Austad Op-Ed on TAME Trial for CNN.com

Jan 15
2016

Board Member in the News: Scientific Director Steven Austad Op-Ed on TAME Trial for CNN.com View MoreBACK

On December 13, 2015, AFAR’s Scientific Director, Steven Austad, PhD, contributed an OpEd to CNN.com entitled, “Could one pill help you live longer?” 

In this piece, Dr. Austad explains that with the potential to cripple health and economic systems, aging represents one of the biggest threats facing the world today. 

This OpEd also lays the answer to common questions on the TAME study including:  Wouldn't such a study take decades and be cripplingly expensive? Why go to the time and expense of doing a clinical trial? What if it doesn't work?.
Read Dr. Austad’s complete article here: http://www.cnn.com/2015/12/11/opinions/austad-pill-longer-life/.

Steven Austad, PhD, is a Distinguished Professor and Department Chair at the University of Alabama, Birmingham.

More information about the TAME (Taming Aging with Metformin) Trial can be found here





View MoreBACK TO TOP